why choose us

First received: February 07, 2023

Clinical Trial: Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hemodynamic Instability

Study Type: INTERVENTIONAL


Official Title: Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

Brief Summary: Two doses of Dexmedetomidine (0.5 µ/kg and 0.75 µ/kg) will be used to attenuate the stress response to laryngoscopy in American Society of Anesthesiology, physical class I patients which will be compared with the placebo-controlled group.

Read more